Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice

Polysaccharide is efficient in attenuation of metabolic ailments and modulation of gut microbiota as prebiotics. The therapeutic effect of Inonotus obliquus polysaccharide (IOP) on chronic pancreatitis (CP) in mice has been validated in our previous study.

However, it is not clear whether IOP is conducive to maintaining the homeostasis between gut microbiota and host. The aim of this study is to testify the potential effects of IOP on gut microbiota composition and diversity in mice with CP.

The changes in glutathione peroxidase (GSH-P X ), total antioxidant capacity (TAOC), tumor necrosis factor alpha (TNF-?), transforming growth factor beta (TGF-?), lipase and trypsin levels were measured by commercial assay kits, meanwhile the gut microbiota composition and diversity were analyzed by high throughput sequencing. The IOP treatment increased GSH-P X and TAOC levels, and decreased TNF-?, TGF-?, lipase and trypsin levels in CP mice.

It was also observed that gut microbiota in IOP treated groups were less diverse than others in terms of lower Shannon diversity index and Chao 1 estimator. IOP increased the proportion of Bacteroidetes and decreased that of Firmicutes at phylum level.

Bacteroidetes was found positively correlated with GSH-P X and TAOC, and Firmicutes correlated with TNF-?, TGF-?, and lipase. In conclusion, administration of IOP could regulate gut microbiota composition and diversity to a healthy profile in mice with CP, and some bacterial phylum significantly correlated with characteristic parameters.

Published on: 2017-02-14

Made available by EUPB via SpringerOpen / BioMedCentral. Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. To submit your press release click here. The full research and author details are available at


Custom Search


© 2017 7thSpace Interactive
All Rights Reserved - About | Disclaimer | Helpdesk